We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

192 hedge funds and large institutions have $6.65B invested in BeOne Medicines Ltd in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 32

140% more call options, than puts

Call options by funds: $50.8M | Put options by funds: $21.1M

117% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 30

56% more funds holding in top 10

Funds holding in top 10: 9 → 14 (+5)

33% more funds holding

Funds holding: 144 → 192 (+48)

0.23% more ownership

Funds ownership: 5.95% → 6.18% (+0.23%)

15% less capital invested

Capital invested by funds: $7.84B → $6.65B (-$1.19B)

Holders
192
Holders Change
+48
Holders Change %
+33.33%
% of All Funds
4.28%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.31%
New
82
Increased
65
Reduced
30
Closed
32
Calls
$50.8M
Puts
$21.1M
Net Calls
+$29.6M
Net Calls Change
+$49.2M

Top Buyers

1
BlackRock
BlackRock
New York
+$186M
2
Capital International Investors
Capital International Investors
California
+$136M
3
Northern Trust
Northern Trust
Illinois
+$74.8M
4
State Street
State Street
Massachusetts
+$68.8M
5
CGT
Capital Guardian Trust
California
+$44.9M

Top Sellers

1
HIM
Hillhouse Investment Management
Cayman Islands
-$589M
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$348M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$315M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.4M
5
Renaissance Technologies
Renaissance Technologies
New York
-$24.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
76
State of Wisconsin Investment Board
Wisconsin
$3.64M +$2.87M +21,635 +503%
N
77
Natixis
France
$3.53M +$3.33M +25,140 New
Mitsubishi UFJ Trust & Banking
78
Mitsubishi UFJ Trust & Banking
Japan
$3.47M +$3.28M +24,727 New
MME
79
Meag Munich Ergo
Germany
$3.06M +$2.93M +22,100 New
UONDDL
80
University of Notre Dame du Lac
Indiana
$2.6M +$208K +1,565 +9%
EU
81
Emory University
Georgia
$2.55M +$202K +1,526 +9%
DekaBank Deutsche Girozentrale
82
DekaBank Deutsche Girozentrale
Germany
$2.42M +$217K +1,635 +10%
Citadel Advisors
83
Citadel Advisors
Florida
$2.38M +$1.48M +11,168 +192%
BNP Paribas Financial Markets
84
BNP Paribas Financial Markets
France
$2.18M -$501K -3,778 -20%
NIP
85
Nicholas Investment Partners
California
$2.15M -$1.16M -8,783 -36%
SAM
86
Sectoral Asset Management
Quebec, Canada
$2.09M +$663K +5,000 +50%
Aviva
87
Aviva
United Kingdom
$2.07M +$1.96M +14,761 New
VIA
88
Vident Investment Advisory
Georgia
$1.97M -$219K -1,655 -11%
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$1.8M -$8.79M -66,320 -84%
ProShare Advisors
90
ProShare Advisors
Maryland
$1.8M -$318K -2,401 -16%
Public Sector Pension Investment Board (PSP Investments)
91
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.79M +$1.69M +12,765 New
Public Employees Retirement Association of Colorado
92
Public Employees Retirement Association of Colorado
Colorado
$1.75M +$1.66M +12,500 New
EIM
93
Essex Investment Management
Massachusetts
$1.53M +$987K +7,443 +216%
JP Morgan Chase
94
JP Morgan Chase
New York
$1.47M -$6.49M -48,914 -82%
MHS
95
M Holdings Securities
Oregon
$1.46M +$715K +5,390 +108%
Aberdeen Group
96
Aberdeen Group
United Kingdom
$1.45M +$1.39M +10,509 New
Barclays
97
Barclays
United Kingdom
$1.44M +$627K +4,731 +86%
NEI
98
Northwest & Ethical Investments
Ontario, Canada
$1.42M +$761K +5,739 +132%
WBC
99
Westpac Banking Corp
Australia
$1.4M +$1.33M +10,008 New
JG
100
Jefferies Group
New York
$1.4M +$511K +3,851 +63%
2 3
4
5 6

ONC Hedge Fund Activity: Q4 2018 in Review

192 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2018, worth a combined $6.65B — down 15% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new ONC positions and 32 closed out — a net gain of 50 holders — while 65 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $186M. The largest seller was Hillhouse Investment Management, cutting an estimated $589M.

  • 192 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2018, up from 144 in Q3 2018.
  • Funds reported $6.65B of BeOne Medicines Ltd stock for Q4 2018, down 15% quarter-over-quarter.
  • 82 funds opened new BeOne Medicines Ltd positions in Q4 2018 and 32 closed out, a net change of +50 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2018 was BlackRock, an estimated $186M added.
  • The largest BeOne Medicines Ltd seller in Q4 2018 was Hillhouse Investment Management, an estimated $589M sold.

Based on aggregated 13F filings for Q4 2018.